Cancer spectrum in DNA mismatch repair gene mutation carriers: results from a hospital based Lynch syndrome registry
- PMID: 22714864
- PMCID: PMC3475767
- DOI: 10.1007/s10689-012-9534-6
Cancer spectrum in DNA mismatch repair gene mutation carriers: results from a hospital based Lynch syndrome registry
Abstract
The spectrum of cancers seen in a hospital based Lynch syndrome registry of mismatch repair gene mutation carriers was examined to determine the distribution of cancers and examine excess cancer risk. Overall there were 504 cancers recorded in 368 mutation carriers from 176 families. These included 236 (46.8 %) colorectal and 268 (53.2 %) extracolonic cancers. MLH1 mutation carriers had a higher frequency of colorectal cancers whereas MSH2, MSH6 and PMS2 mutation carriers had more extracolonic cancers although these differences were not statistically significant. Men had fewer extracolonic cancers than colorectal (45.3 vs. 54.7 %), whereas women had more extracolonic than colorectal cancers (59.0 vs. 41.0 %). The mean age at diagnosis overall for extracolonic cancers was older than for colorectal, 49.1 versus 44.8 years (P ≤ 0.001). As expected, the index cancer was colorectal in 58.1 % of patients and among the extracolonic index cancers, endometrial was the most common (13.8 %). A significant number of non-Lynch syndrome index cancers were recorded including breast (n = 5) prostate (n = 3), thyroid (n = 3), cervix (n = 3), melanoma (n = 3), and 1 case each of thymoma, sinus cavity, and adenocarcinoma of the lung. However, standardized incidence ratios calculated to assess excess cancer risk showed that only those cancers known to be associated with Lynch syndrome were significant in our sample. We found that Lynch syndrome patients can often present with cancers that are not considered part of Lynch syndrome. This has clinical relevance both for diagnosis of Lynch syndrome and surveillance for cancers of different sites during follow-up of these patients.
Figures
Similar articles
-
Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome.J Natl Cancer Inst. 2012 Sep 19;104(18):1363-72. doi: 10.1093/jnci/djs351. Epub 2012 Aug 28. J Natl Cancer Inst. 2012. PMID: 22933731 Free PMC article.
-
Commentary on "Risks of primary extracolonic cancers following colorectal cancer in Lynch syndrome." Win AK, Lindor NM, Young JP, Macrae FA, Young GP, Williamson E, Parry S, Goldblatt J, Lipton L, Winship I, Leggett B, Tucker KM, Giles GG, Buchanan DD, Clendenning M, Rosty C, Arnold J, Levine AJ, Haile RW, Gallinger S, Le Marchand L, Newcomb PA, Hopper JL, Jenkins MA, Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, Melbourne School of Population Health, The University of Melbourne, Victoria, Australia: J Natl Cancer Inst 2012;104(18):1363-72 [Epub 2012 Aug 28].Urol Oncol. 2013 Jul;31(5):716. doi: 10.1016/j.urolonc.2013.03.013. Urol Oncol. 2013. PMID: 23796201
-
Risks of colorectal and other cancers after endometrial cancer for women with Lynch syndrome.J Natl Cancer Inst. 2013 Feb 20;105(4):274-9. doi: 10.1093/jnci/djs525. Epub 2013 Feb 5. J Natl Cancer Inst. 2013. PMID: 23385444 Free PMC article.
-
[Colorectal Carcinoma with Suspected Lynch Syndrome: A Multidisciplinary Algorithm].Zentralbl Chir. 2015 Dec;140(6):591-9. doi: 10.1055/s-0034-1368480. Epub 2014 Nov 5. Zentralbl Chir. 2015. PMID: 25372301 Review. German.
-
Lynch syndrome: a pediatric perspective.J Pediatr Gastroenterol Nutr. 2014 Feb;58(2):144-52. doi: 10.1097/MPG.0000000000000179. J Pediatr Gastroenterol Nutr. 2014. PMID: 24051481 Review.
Cited by
-
Hereditary Predisposition to Prostate Cancer: From Genetics to Clinical Implications.Int J Mol Sci. 2020 Jul 16;21(14):5036. doi: 10.3390/ijms21145036. Int J Mol Sci. 2020. PMID: 32708810 Free PMC article. Review.
-
Therapeutic implications of germline vulnerabilities in DNA repair for precision oncology.Cancer Treat Rev. 2022 Mar;104:102337. doi: 10.1016/j.ctrv.2021.102337. Epub 2022 Jan 5. Cancer Treat Rev. 2022. PMID: 35051883 Free PMC article. Review.
-
A deep learning approach to identify gene targets of a therapeutic for human splicing disorders.Nat Commun. 2021 Jun 7;12(1):3332. doi: 10.1038/s41467-021-23663-2. Nat Commun. 2021. PMID: 34099697 Free PMC article.
-
Pathogenic Insights into DNA Mismatch Repair (MMR) Genes-Proteins and Microsatellite Instability: Focus on Adrenocortical Carcinoma and Beyond.Diagnostics (Basel). 2023 May 26;13(11):1867. doi: 10.3390/diagnostics13111867. Diagnostics (Basel). 2023. PMID: 37296718 Free PMC article. Review.
-
Targeted DNA Sequencing Detects Mutations Related to Susceptibility among Familial Non-medullary Thyroid Cancer.Sci Rep. 2015 Nov 4;5:16129. doi: 10.1038/srep16129. Sci Rep. 2015. PMID: 26530882 Free PMC article.
References
-
- Geary J, Sasieni P, Houlston R, Izatt L, Eeles R, Payne SJ, Fisher S, Hodgson SV. Gene-related cancer spectrum in families with hereditary non-polyposis colorectal cancer (HNPCC) Fam Cancer. 2008;7:163–172. - PubMed
-
- Pinol V, Castells A, Andreu M, Castellvi-Bel S, Alenda C, Llor X, Xicola RM, Rodriguez-Moranta F, Paya A, Jover R, Bessa X. Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. JAMA. 2005;293:1986–1994. - PubMed
-
- Salovaara R, Loukola A, Kristo P, Kaariainen H, Ahtola H, Eskelinen M, Harkonen N, Julkunen R, Kangas E, Ojala S, Tulikoura J, Valkamo E, Jarvinen H, Mecklin JP, Aaltonen LA, de la Chapelle A. Population-based molecular detection of hereditary nonpolyposis colorectal cancer. J Clin Oncol. 2000;18:2193–2200. - PubMed
-
- Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, Clendenning M, Sotamaa K, Prior T, Westman JA, Panescu J, Fix D, Lockman J, LaJeunesse J, Comeras I, de la Chapelle A. Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J Clin Oncol. 2008;26:5783–5788. - PMC - PubMed
-
- Lynch HT, Ens J, Lynch JF, Watson P. Tumor variation in three extended Lynch syndrome II kindreds. Am J Gastroenterol. 1988;83:741–747. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous